• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在整群随机试验中存在效应修饰因素数据缺失的情况下评估治疗效果异质性。

Assessing treatment effect heterogeneity in the presence of missing effect modifier data in cluster-randomized trials.

作者信息

Blette Bryan S, Halpern Scott D, Li Fan, Harhay Michael O

机构信息

Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.

Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Stat Methods Med Res. 2024 May;33(5):909-927. doi: 10.1177/09622802241242323. Epub 2024 Apr 3.

DOI:10.1177/09622802241242323
PMID:38567439
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11041086/
Abstract

Understanding whether and how treatment effects vary across subgroups is crucial to inform clinical practice and recommendations. Accordingly, the assessment of heterogeneous treatment effects based on pre-specified potential effect modifiers has become a common goal in modern randomized trials. However, when one or more potential effect modifiers are missing, complete-case analysis may lead to bias and under-coverage. While statistical methods for handling missing data have been proposed and compared for individually randomized trials with missing effect modifier data, few guidelines exist for the cluster-randomized setting, where intracluster correlations in the effect modifiers, outcomes, or even missingness mechanisms may introduce further threats to accurate assessment of heterogeneous treatment effect. In this article, the performance of several missing data methods are compared through a simulation study of cluster-randomized trials with continuous outcome and missing binary effect modifier data, and further illustrated using real data from the Work, Family, and Health Study. Our results suggest that multilevel multiple imputation and Bayesian multilevel multiple imputation have better performance than other available methods, and that Bayesian multilevel multiple imputation has lower bias and closer to nominal coverage than standard multilevel multiple imputation when there are model specification or compatibility issues.

摘要

了解治疗效果在亚组间是否存在差异以及如何存在差异,对于指导临床实践和建议至关重要。因此,基于预先指定的潜在效应修饰因素评估异质性治疗效果已成为现代随机试验的一个共同目标。然而,当一个或多个潜在效应修饰因素缺失时,完全病例分析可能会导致偏差和覆盖不足。虽然已经提出并比较了处理个体随机试验中效应修饰因素数据缺失的统计方法,但对于整群随机试验设置,几乎没有相关指南,因为效应修饰因素、结局甚至缺失机制中的组内相关性可能会对异质性治疗效果的准确评估带来进一步的威胁。在本文中,通过对具有连续结局和二元效应修饰因素数据缺失的整群随机试验进行模拟研究,比较了几种缺失数据方法的性能,并使用来自工作、家庭和健康研究的真实数据进行了进一步说明。我们的结果表明,多层多重插补和贝叶斯多层多重插补比其他可用方法具有更好的性能,并且当存在模型设定或兼容性问题时,贝叶斯多层多重插补比标准多层多重插补具有更低的偏差且更接近名义覆盖率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a15e/11041086/17a636bb0a14/10.1177_09622802241242323-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a15e/11041086/67edc6a0620a/10.1177_09622802241242323-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a15e/11041086/ac490f58ed1b/10.1177_09622802241242323-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a15e/11041086/7b999c7a2f4a/10.1177_09622802241242323-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a15e/11041086/a8e0064bb041/10.1177_09622802241242323-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a15e/11041086/17a636bb0a14/10.1177_09622802241242323-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a15e/11041086/67edc6a0620a/10.1177_09622802241242323-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a15e/11041086/ac490f58ed1b/10.1177_09622802241242323-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a15e/11041086/7b999c7a2f4a/10.1177_09622802241242323-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a15e/11041086/a8e0064bb041/10.1177_09622802241242323-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a15e/11041086/17a636bb0a14/10.1177_09622802241242323-fig5.jpg

相似文献

1
Assessing treatment effect heterogeneity in the presence of missing effect modifier data in cluster-randomized trials.在整群随机试验中存在效应修饰因素数据缺失的情况下评估治疗效果异质性。
Stat Methods Med Res. 2024 May;33(5):909-927. doi: 10.1177/09622802241242323. Epub 2024 Apr 3.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Properties and pitfalls of weighting as an alternative to multilevel multiple imputation in cluster randomized trials with missing binary outcomes under covariate-dependent missingness.在协变量相关缺失下缺失二分类结局的群组随机试验中,加权作为多水平多重插补替代方法的性质和陷阱。
Stat Methods Med Res. 2020 May;29(5):1338-1353. doi: 10.1177/0962280219859915. Epub 2019 Jul 11.
4
Imputation strategies for missing binary outcomes in cluster randomized trials.在整群随机试验中缺失二分类结局的处理策略。
BMC Med Res Methodol. 2011 Feb 16;11:18. doi: 10.1186/1471-2288-11-18.
5
Multiple imputation methods for bivariate outcomes in cluster randomised trials.整群随机试验中双变量结局的多重填补方法。
Stat Med. 2016 Sep 10;35(20):3482-96. doi: 10.1002/sim.6935. Epub 2016 Mar 14.
6
Should multiple imputation be the method of choice for handling missing data in randomized trials?在随机试验中,处理缺失数据时是否应选择多重插补法?
Stat Methods Med Res. 2018 Sep;27(9):2610-2626. doi: 10.1177/0962280216683570. Epub 2016 Dec 19.
7
Hierarchical Bayesian modeling of heterogeneous outcome variance in cluster randomized trials.分层贝叶斯模型在群组随机试验中异质结局方差的应用。
Clin Trials. 2024 Aug;21(4):451-460. doi: 10.1177/17407745231222018. Epub 2024 Jan 10.
8
Accounting for expected attrition in the planning of cluster randomized trials for assessing treatment effect heterogeneity.在规划评估治疗效果异质性的群组随机试验时,考虑预期的损耗。
BMC Med Res Methodol. 2023 Apr 6;23(1):85. doi: 10.1186/s12874-023-01887-8.
9
Imputation strategies for missing continuous outcomes in cluster randomized trials.整群随机试验中连续缺失结局的插补策略。
Biom J. 2008 Jun;50(3):329-45. doi: 10.1002/bimj.200710423.
10
Missing continuous outcomes under covariate dependent missingness in cluster randomised trials.整群随机试验中协变量依赖型缺失情况下连续结局的缺失问题
Stat Methods Med Res. 2017 Jun;26(3):1543-1562. doi: 10.1177/0962280216648357. Epub 2016 May 13.

本文引用的文献

1
A BAYESIAN MACHINE LEARNING APPROACH FOR ESTIMATING HETEROGENEOUS SURVIVOR CAUSAL EFFECTS: APPLICATIONS TO A CRITICAL CARE TRIAL.一种用于估计异质幸存者因果效应的贝叶斯机器学习方法:在重症监护试验中的应用
Ann Appl Stat. 2024 Mar;18(1):350-374. doi: 10.1214/23-aoas1792. Epub 2024 Jan 31.
2
Sample size requirements for testing treatment effect heterogeneity in cluster randomized trials with binary outcomes.检验二分类结局的群组随机试验中处理效应异质性的样本量要求。
Stat Med. 2023 Nov 30;42(27):5054-5083. doi: 10.1002/sim.9901. Epub 2023 Sep 14.
3
Sample Size Requirements to Test Subgroup-Specific Treatment Effects in Cluster-Randomized Trials.
检验群组随机试验中特定亚组治疗效果的样本量要求。
Prev Sci. 2024 Jul;25(Suppl 3):356-370. doi: 10.1007/s11121-023-01590-6. Epub 2023 Oct 10.
4
Maximin optimal cluster randomized designs for assessing treatment effect heterogeneity.最大最小最优区组随机设计评估治疗效应异质性。
Stat Med. 2023 Sep 20;42(21):3764-3785. doi: 10.1002/sim.9830. Epub 2023 Jun 20.
5
Sample size considerations for assessing treatment effect heterogeneity in randomized trials with heterogeneous intracluster correlations and variances.评估具有异质聚类相关系数和方差的随机试验中治疗效果异质性的样本量考虑。
Stat Med. 2023 Aug 30;42(19):3392-3412. doi: 10.1002/sim.9811. Epub 2023 Jun 14.
6
Accounting for expected attrition in the planning of cluster randomized trials for assessing treatment effect heterogeneity.在规划评估治疗效果异质性的群组随机试验时,考虑预期的损耗。
BMC Med Res Methodol. 2023 Apr 6;23(1):85. doi: 10.1186/s12874-023-01887-8.
7
Health equity considerations in pragmatic trials in Alzheimer's and dementia disease: Results from a methodological review.阿尔茨海默病和痴呆症实用试验中的健康公平考量:一项方法学综述的结果
Alzheimers Dement (Amst). 2023 Feb 5;15(1):e12392. doi: 10.1002/dad2.12392. eCollection 2023 Jan-Mar.
8
Designing three-level cluster randomized trials to assess treatment effect heterogeneity.设计三级整群随机临床试验评估治疗效果异质性。
Biostatistics. 2023 Oct 18;24(4):833-849. doi: 10.1093/biostatistics/kxac026.
9
Estimands in cluster-randomized trials: choosing analyses that answer the right question.在整群随机临床试验中的估算指标:选择回答正确问题的分析方法。
Int J Epidemiol. 2023 Feb 8;52(1):107-118. doi: 10.1093/ije/dyac131.
10
Accounting for unequal cluster sizes in designing cluster randomized trials to detect treatment effect heterogeneity.在设计用于检测治疗效果异质性的整群随机试验时,考虑不等的群组大小。
Stat Med. 2022 Apr 15;41(8):1376-1396. doi: 10.1002/sim.9283. Epub 2021 Dec 19.